Global Antibiotic Research & Development Partnership (GARDP) and REVIVE
Global Antibiotic Research & Development Partnership (GARDP) and REVIVE The growing concern over drug-resistant bacterial infections is coupled with a troubling slowdown in the discovery and development of new treatments. Many companies and academic laboratories have discontinued their work in antimicrobial research and development (R&D), raising the risk of losing valuable expertise in this critical field. Collaborating with a range of partners from the public, private, and non-profit sectors, the Global Antibiotic Research & Development Partnership (GARDP) GARDP aims to preserve and apply valuable knowledge for future generations. To address this goal, GARDP’s Scientific Affairs team has launched a series of initiatives [...]